Back to Results
First PageMeta Content
Medicine / Arthritis / Autoimmune diseases / Connective tissue diseases / Monoclonal antibodies / Disease-modifying antirheumatic drug / Leflunomide / Rheumatoid arthritis / Psoriatic arthritis / Immunosuppressants / Immunology / Health


Health and Community Services The Newfoundland and Labrador Prescription Drug Program CRITERIA FOR THE COVERAGE OF SPECIAL AUTHORIZATION DRUGS Subject to revision Coverage of special authorization drugs will be approved
Add to Reading List

Document Date: 2014-11-07 11:38:22

Open Document

File Size: 1,91 MB

Share Result on Facebook

Facility

American College of Rheumatology / /

IndustryTerm

treatment of metastatic prostate cancer / treatment of chronic obstructive pulmonary disease / /

MedicalCondition

metastatic prostate cancer / COPD / respiratory failure / disease / Ankylosing Spondylitis / shortness of breath / chronic obstructive pulmonary disease / Rheumatoid Arthritis / chronic / Juvenile Idiopathic Arthritis/ Juvenile Rheumatoid Arthritis / heart failure / juvenile idiopathic arthritis / juvenile rheumatoid arthritis / Psoriasis / prostate cancer / Psoriatic Arthritis / uveitis / /

MedicalTreatment

antibiotics / immunosuppressive therapy / chemotherapy / /

Organization

the American College / Pharmaceutical Services Division / /

Position

Governor / physician / /

Product

Humira / Campral 333mg / 100mg / Orencia / MG TABLET / leflunomide / cyclosporine / Campral / sulfasalazine / prednisone / azathioprine / Symbicort / RA Medication / /

Technology

chemotherapy / /

URL

http /

SocialTag